HYOSCINE HYDROCHLORIDE

CAS No. 55-16-3

HYOSCINE HYDROCHLORIDE( —— )

Catalog No. M20466 CAS No. 55-16-3

HYOSCINE HYDROCHLORIDE versus placebo in preventing motion sickness has been shown to be effective.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 49 In Stock
25MG 75 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    HYOSCINE HYDROCHLORIDE
  • Note
    Research use only, not for human use.
  • Brief Description
    HYOSCINE HYDROCHLORIDE versus placebo in preventing motion sickness has been shown to be effective.
  • Description
    HYOSCINE HYDROCHLORIDE versus placebo in preventing motion sickness has been shown to be effective.
  • In Vitro
    Scopolamine blocks nicotinic acetylcholine receptors (IC50=928 μM) and increases the expression of α7 nACh receptors. Scopolamine displays concentration-dependent competition with 0.6 nM [3H]Granisetron, yielding an average pKi of 5.17±0.24 (Ki=6.76 μM). Concentration-dependent competition of fluorescently labeled form of granisetron (G-FL) with Scopolamine gives an average pKi of 5.31±0.09 (Ki=4.90 μM).Scopolamine blocks muscarinic receptors and induces a cognitive deficit.Scopolamine (0.1-3 mM; for 24 hours) induces cytotoxicity, ROS generation and apoptosis of SH-SY5Y cells.Cell Viability Assay Cell Line:Human neuroblastoma SH-SY5Y cell line Concentration:0.1-3 mM (usually 2 mM) Incubation Time:24 hours Result:Exposure to 1-3 mM for 24 hours significantly decreased human neuroblastoma SH-SY5Y cell viability in a dose-dependent manner. In all subsequent experiments, 2 M resulted in 50.6±2.2% loss in cell viability.
  • In Vivo
    Scopolamine induces memory impairment associated with attenuation of cholinergic neurotransmission, as well as an increases of processes connected with oxidative stress in the brain. Animal Model:Naive male Swiss mice weighing 20-25 Dosage:1mg/kg Administration: Administered intraperitoneally (i.p.); to measure the memory acquisition processes, Scopolamine was administered 20 min before the pretest; to measure the memory consolidation processes, Scopolamine was administered immediately after the pretest Result:In scopolamine-treated group, there was a significant decrease in the index of latency (IL) value as compared with the saline-treated mice, indicating that scopolamine at the used dose impaired acquisition of memory and learning.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    55-16-3
  • Formula Weight
    339.8
  • Molecular Formula
    C17H22ClNO4?
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cl.[H][C@@]12O[C@]1([H])[C@H]1C[C@H](C[C@@H]2N1C)OC(=O)[C@H](CO)c1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Spinks A Wasiak J . Scopolamine (hyoscine) for preventing and treating motion sickness[J]. Cochrane database of systematic reviews (Online) 2011(6):CD002851.
molnova catalog
related products
  • Gymnoside III

    Gymnoside III is a natural product from Gymnadenia conopsea.

  • Maoyerabdosin

    Maoyerabdosin is a kind of natural product derived from the herbs of Isodon.

  • Mal-PEG5-Boc

    Mal-PEG5-Boc is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.